Insilico completes HK$2.28bn HK IPO

Drug discovery software company Insilico Medicine has raised HK$2.28bn (US$293m) from a Hong Kong IPO.

EQY
OneRobotics prices HK IPO at upper half of range

OneRobotics (Shenzhen) has priced its Hong Kong IPO at the upper half of the range at HK$73.80 per share to raise HK$1.6bn (US$206m), people with knowledge of the matter said.

EQY
Xunce prices HK IPO at bottom of range

Chinese data infrastructure and analytics company Shenzhen Xunce Technology has priced its Hong Kong IPO at the bottom of the range at HK$48 per share to raise HK$1.08bn (US$139m), said people with knowledge of the matter.

EQY
ASG Hospital plans up to US$500m IPO

India's ASG Eye Hospital is planning a US$400m–$500m IPO next year and is in the process of finalising the syndicate, people with knowledge of the transaction said. 

EQY
Beijing 51World, Forest Cabin wrap up HK IPOs

Beijing 51World Digital Twin Technology has raised HK$732m (US$94.1m) from a Hong Kong IPO.

EQY

Latest Equities Stories By Region and Type

Americas
Europe, Middle East and Africa
Asia / Pacific
Initial Public Offerings (IPO)
Structured Equity
Americas
  • Americas
  • Europe, Middle East and Africa
  • Asia / Pacific
  • Initial Public Offerings (IPO)
  • Structured Equity

IFR US ECM Weekly Review

Klein's Churchill Capital XI raises US$360m

Zoetis gains lift from US$1.75bn CB

Updated:

Andersen pops on debut after high-end IPO pricing

Updated:

Bain cuts stake in BRP via C$185m stock sale

Updated:

Kyverna raises US$100m after brief holdup

IFR US ECM Pricings

Medline's US$7.2bn IPO sets stage for PE exits

Kodiak's US$160m stock sale de-risks drug trials

Immunome secures US$400m for drug launch

Updated: